Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG
02 1Supriya Lifescience
03 1Chunghwa Chemical Synthesis & Biotech
04 1Rochem International Inc
05 1ChemWerth Inc
06 1Transo-Pharm USA LLC
07 1LGM Pharma
08 1Inabata France S.A.S
09 1Faran Shimi Pharmaceutical
10 1Chongqing Sintaho Pharmaceutical
11 1HRV Global Life Sciences
12 1Neuland Laboratories
13 1Shanghai Minbiotech
14 1Omgene Life Sciences Pvt. Ltd
15 1TAPI Technology & API Services
16 1ALP Pharm
17 1Alembic Pharmaceuticals Limited
18 1AmbioPharm
19 1Anthem Biosciences
20 1Apicore LLC
21 1Apino Pharma
22 1Asymchem Laboratories
23 1Aurisco Pharmaceutical
24 1Aurobindo Pharma Limited
25 1Beijing QL Biopharmaceutical
26 1CBL- Chemical and Biopharmaceutical Laboratories
27 1Chengdu Shengnuo Biopharm
28 1Chinese Peptide Company
29 1Chongqing Zhifei Biological Products
30 1Dalian Richon Chem
31 2Fujian Genohope Biotech
32 1Hangzhou Go Top Peptide Biotech Co.,Ltd
33 1Hangzhou Jiuyuan Gene Engineering
34 1Hangzhou Zhongmei Huadong Pharmaceutical
35 1Hanways Chempharm
36 1Huisheng Biopharmaceutical
37 1Hybio Pharmaceutical
38 1Jin Dun Medical
39 1MSN Laboratories
40 1Mankind Pharma
41 1Micro Labs Limited
42 1Piramal Pharma Solutions
43 2PolyPeptide Group
44 1Prajna Generics
45 1Shenzhen JYMed Technology
46 1Sinopep Pharmaceutical Inc
47 1Smaart Pharmaceutticals
48 1Sun Pharmaceutical Industries Limited
49 1Suzhou Tianma Pharma Group Co Ltd
50 1Viatris
51 1Xiamen SINOPEG Biotech
52 1Zhejiang Peptites Biotech Co.,Ltd
53 1Zydus Lifesciences
54 8Blank
01 24China
02 1France
03 1Greece
04 15India
05 1Iran
06 1Israel
07 3Switzerland
08 1Taiwan
09 8U.S.A
10 8Blank
01 33Active
02 30Blank
01 63Blank
01 63Blank
01 63Blank
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-04-30
Pay. Date : 2023-03-02
DMF Number : 37594
Submission : 2023-03-16
Status : Active
Type : II
NDC Package Code : 55463-0040
Start Marketing Date : 2024-04-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
NDC Package Code : 61281-8600
Start Marketing Date : 2024-09-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6282
Start Marketing Date : 2024-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
We have 53 companies offering Semaglutide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?